Richard J. Deckelbaum, MD, CM, FRCPC

Expertise in: 
Pediatric Gastroenterology
Board Certifications: 
Pediatrics
Treats Children
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Pediatric Gastroenterology

Academic Appointments

  • Professor of Epidemiology
  • Robert R. Williams Professor of Nutrition (in Pediatrics)

Administrative Titles

  • Director, Institute of Human Nutrition

Richard J. Deckelbaum, MD - Robert R. Williams Professor of Nutrition

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Morgan Stanley Children's Hospital

Languages

  • Hebrew
  • French

Gender

  • Male

Location(s)

CUMC/NewYork-Presbyterian Morgan Stanley Children's Hospital
3959 Broadway
New York, NY 10032
Primary

Credentials & Experience

Education & Training

  • McGill University Faculty of Medicine
  • Residency: Montreal Children's Hospital
  • Fellowship: Montreal Children's Hospital

Board Certifications

  • Pediatrics

Research

The major focus of Dr. Deckelbaum’s laboratory is to determine regulatory mechanisms for cell-lipid particle interaction, and cell cholesterol and triglyceride metabolism. Current projects are defining the effects of lipid particle properties on their metabolism in the whole animal, and in cells, via receptor-mediated and receptor-independent pathways. Integrated with these studies are studies on how different lipids, omega-3 and other free fatty acids regulate gene expression and focus on genes and mechanisms affecting atherogenesis, myocardial infarction and stroke. Dr. Deckebaum’s initial research training as a postdoctoral fellow in biophysics using NMR, calorimetry, and X-ray techniques to study the structure of lipoproteins has allowed him throughout his career to understand the importance of physical structure of different lipids in the biochemistry and in the molecular biology of lipids and lipid metabolism. Having been funded continuously for over thirty years by NIH R01s and PPGs focusing on triglyceride emulsions, lipoprotein metabolism, and lipid metabolism in in vitro and in vivo, we have obtained very exciting results over the years showing that EPA/DHA rich diets have the ability to inhibit pathways associated with atherogenesis in four different rodent models. Our laboratory has shown that acute administration of omega-3 fatty acids also provides major neuro- and cardioprotection after stroke and myocardial infarction in rodent models. Of the pre- and postdoctoral trainees Dr. Deckelbaum has mentored over the past 30 years, over 45 now have full-time academic positions at universities or are heading nutrition-related roles in industry and government.

Grants

NIH RO1 NS088197, RJ Deckelbaum (PI) 04/01/15-03/31/20 “Omega-3 Fatty Acids: Acute Neuroprotection via Mitochondria”
 
NIH 2P30 DK63068-06, D Accili (PI); RJ Deckelbaum (Mentor) 02/01/08-01/31/23 “Diabetes and Endocrinology Center”
 
NIH T32 DK07647-26, RJ Deckelbaum (Co-PI) 09/01/95-08/31/20  “Graduate Training in Nutrition”
 
NIH R01 HL141823, A Moran (PI); RJ Deckelbaum (Co-PI)  09/01/18-08/31/23  “Familial hypercholesterolemia screening in children: population impact of phenotype, genotype and cascade approaches”
 
Private, RJ Deckelbaum (PI) 06/01/16-12/31/19
“Characterization and Effects of an MCT-Fish Oil Intravenous Lipid Emulsion in Rodent Models”
 

FAMILIAL HYPERCHOLESTEROLEMIA SCREENING IN CHILDREN: POPULATION IMPACT OF PHENOTYPE, GENOTYPE, AND CASCADE APPROACHES (Federal Gov)

Feb 1 2019 - Apr 30 2023